In our study, we therefore excluded patients with factors that may affect LOXL2, such as HF, tumors, and pulmonary fibrosis, and found that LOXL2 was significantly higher in patients with AF than those without AF, indicating that LOXL2 may be involved in the pathogenesis of AF. This evidence concerns the gene LOXL2 and pulmonary fibrosis.